Press "Enter" to skip to content

New “Chemputer” System Might Modernize Drug Production

A new technique has been developed by researchers from the University of Glasgow, UK, to synthesize drug molecules. The scientists state that the technique utilizes downloadable blueprints to simply and consistently produce organic chemicals through a programmable “chemputer.” And also believe that this technique can democratize the pharmaceutical industry.

For the foremost time, the scientists demonstrate how synthesis of significant drug molecules can be obtained in a reasonable and modular chemical–robot system they refer as a chemputer. Though recent enhancements in chemical production have enabled few chemical compounds to be synthesized through automated systems at laboratory scale, the chemputer is strengthened by a new widespread and interoperable standard for sharing and writing chemical recipes. The aim was to build a general reflection for chemistry that can be made realistic, universal, and stimulated by a computer program, said scientists.

Those chemical recipes, processed on a computer program the team denotes as “chempiler,” teach the chemputer how to generate molecules on-demand, more safely and affordably than ever feasible before, said researchers. The scientists claim the capability to utilize a universal code will enable chemists worldwide to translate their formula into a digital code. This will enable others to download and share recipes in a similar manner to music on Spotify or iTunes nowadays, they said.

The prospective applications are vast, and we are extremely thrilled to be leading on this ground-breaking new advancement to organic chemistry.

Likewise, a category of cancer drugs known as protein kinase inhibitors is among the most effectual therapies for melanoma. Nonetheless, in several instances, tumors in due course become defiant to the drugs and bring about a relapse in the individual.

A new research from MIT proposes that merging kinase inhibitors together with experimental drugs called ribonucleases can result in better outcomes. In experiments with human cancer cells, the scientists discovered that the 2 drugs administered together destroy cells much more efficiently than either medication does on its own.